Blood Plasma Derivatives Market Size 2022, Top Companies Overview, Share, Trends, Growth and Forecast

The latest research study "Blood Plasma Derivatives Market: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global blood plasma derivatives market reached a value of US$ 40.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 59.8 Billion by 2027, exhibiting a CAGR of 6.40% during 2022-2027.

Blood plasma derivatives are concentrated proteins prepared from plasma that is separated through physico-chemical or other fractionation processes and traced based on the lot or batch number. These derivatives are rich in proteins, salts, hormones, protease inhibitors, minerals, and vitamins. Consequently, they help control body temperature and coagulation of blood, maintain osmotic pressure, enhance respiration and excretion, and regulate acid-base balance. Owing to these properties, blood plasma derivatives are widely used to kill viruses that cause hepatitis B, bleeding disorders, hemophilia A, immunodeficiency, hepatitis C, and human immunodeficiency virus (HIV).

Download a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Blood Plasma Derivatives Market Trends and Drivers:

The market is primarily driven by the rising geriatric population that is more susceptible to developing infectious diseases. Besides this, the increasing adoption of convalescent plasma therapy to treat coronavirus disease (COVID-19) patients is also contributing to the market growth.

In addition, the market is further propelled by the development of advanced preservation methods and significant improvements in encased procedures that aid in developing targeted therapeutic products. Along with this, various technological innovations in the fractionation process that help separate protein concentrates and other blood plasma components for clinical purposes are also providing a thrust to the market growth.

Moreover, governments of numerous countries are continuously increasing awareness regarding blood and plasma donation among the masses by organizing blood donation camps. On account of these factors, the market is expected to witness positive growth in the coming years.

Global Blood Plasma Derivatives Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

The report has segmented the market on the basis of region, type, application and end user.

Breakup by Type:
• Albumin
• Factor VIII
• Factor IX
• Immunoglobulin
• Hyperimmune Globulin
• Others

Breakup by Application:
• Hemophilia
• Hypogammaglobulinemia
• Immunodeficiency Diseases
• Von Willebrand's Disease
• Others

Breakup by End User:
• Hospitals
• Clinics
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/blood-plasma-derivatives-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Also, Read Latest Research Reports by IMARC Group:

Veterinary Service Market Report 2022-2027 : https://www.imarcgroup.com/veterinary-service-market

Autoinjector Market Report 2022-2027 : https://www.imarcgroup.com/autoinjector-market

Oncology Based In-Vivo CRO Market Report 2022-2027 : https://www.imarcgroup.com/oncology-based-in-vivo-cro-market

Anti-Obesity Drugs Market Report 2022-2027 : https://www.imarcgroup.com/anti-obesity-drugs-market

Animal Wound Care Market Report 2022-2027 : https://www.imarcgroup.com/animal-wound-care-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.